garcinol has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biersack, B; Corona, A; Schaller, D; Schobert, R; Seibt, S; Tramontano, E; Volkamer, A | 1 |
| Ahmad, A; Oswal, N; Padhye, S; Sarkar, FH | 1 |
1 review(s) available for garcinol and HIV Coinfection
| Article | Year |
|---|---|
Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs.
Topics: Animals; Antineoplastic Agents; Antioxidants; Chalcone; Chalcones; Garcinia; HIV Infections; Humans; Inflammation; Models, Biological; Neoplasms; Terpenes | 2009 |
1 other study(ies) available for garcinol and HIV Coinfection
| Article | Year |
|---|---|
Garcinol from Garcinia indica inhibits HIV-1 reverse transcriptase-associated ribonuclease H.
Topics: Garcinia; HIV Infections; HIV-1; Molecular Docking Simulation; Reverse Transcriptase Inhibitors; Ribonuclease H, Human Immunodeficiency Virus; Terpenes | 2021 |